'Alzheimer protein' seems to slow down neurotransmitter production

RUB researchers analyze proteome of cells

2012-08-21

(Press-News.org) How abnormal protein deposits in the brains of Alzheimer's patients disrupt the signalling between nerve cells has now been reported by researchers in Bochum and Munich, led by Dr. Thorsten Müller from the Medizinisches Proteom-Center of the Ruhr-Universität, in the journal Molecular and Cellular Proteomics. They varied the amount of APP protein and related proteins associated with Alzheimer's disease in cell cultures, and then analysed how this manipulation affected other proteins in the cell. The result: the amount of APP present was related to the amount of an enzyme that is essential for the production of neurotransmitters and therefore for communication amongst nerve cells.

Proteomics: analysing all the proteins of the cells at once

Amyloid plaques are a characteristic feature of Alzheimer's disease. They consist largely of cleavage products of the so-called amyloid precursor protein APP, which occur in excess in the brains of Alzheimer's patients. What role APP plays in healthy people and why the abnormal accumulation of amyloid disrupts the regular functioning of the brain is still largely unclear. To understand the function of APP, the RUB researchers established a new cell model. The new cells produced only a very small amount of APP. What impact this had on all the other proteins of these cells was examined by the researchers through the use of mass spectrometry, among other things. With this method they identified over 2000 proteins and determined their concentrations. They were looking specifically for molecules whose concentrations in the newly established low-APP cells were different than in the reference cells that contained normal amounts of APP.

Abnormal protein able to curb neurotransmitter production

"One candidate has particularly caught our attention, this being the enzyme methionine adenosyltransferase II, alpha, MAT2A for short", Thorsten Müller said. Among other things, the enzyme is crucially involved in the production of neurotransmitters. Low-APP cells contained less MAT2A than the reference cells. To confirm the connection between the "Alzheimer's protein" APP and the neurotransmitter-producing MAT2A, the team studied tissue samples from the brains of deceased Alzheimer's patients and from healthy individuals. In the tissue of the Alzheimer's patients there was less MAT2A than in the healthy samples. These results suggest that APP and MAT2A concentrations are related and are linked to the synthesis of neurotransmitters. "Our results point to a new mechanism by which the defective cleavage of the APP protein in Alzheimer's disease could be directly related to altered neurotransmitter production", Müller said. "As a result, the signal transduction of nerve cells could be disrupted, which, over an extended period, could possibly also cause the death of cells."

###Bibliographic record

A. Schrötter, K. Pfeiffer, F. El Magraoui, H. Platta, R. Erdmann, Helmut E. Meyer, R. Egensperger, K. Marcus, T. Müller (2012): The APP family members are key players in S-adenosylmethionine formation by MAT2A and modify BACE1 and PSEN1 gene expression - relevance for Alzheimer's disease, Molecular and Cellular Proteomics, doi: 10.1074/mcp.M112.019364

Figures online

Three photos related to this press release are available online at: http://aktuell.ruhr-uni-bochum.de/pm2012/pm00273.html.en

Further information

Dr. Thorsten Müller, Functional Proteomics, Medizinisches Proteom-Center at the Ruhr-Universität, 44780 Bochum, Germany, Tel.
+49/234/32-29265
thorsten.t.mueller@rub.de

Click for more

Medizinisches Proteom-Center
http://www.medizinisches-proteom-center.de/index.php?lang=en

Editor: Dr. Julia Weiler

ELSE PRESS RELEASES FROM THIS DATE:

New attack on pain

2012-08-21

The research relates to a family of molecules firstly discovered in Melbourne that applied to blood cell development. One of these, granulocyte macrophage colony-stimulating factor or GM-CSF, acts as a messenger between cells acting at a site of inflammation. Professor John Hamilton has posed the question: could blocking GM-CSF action lead to a new treatment for inflammatory diseases? In experimental models of rheumatoid arthritis, Professor Hamilton and Dr Andrew Cook had previously shown that blocking GM-CSF function with an antibody suppressed the disease leading to ...

Viruses with integrated gene switch

2012-08-21

Numerous viruses are used in the service of science today. They serve as gene taxis to transfer therapeutic genes into body cells or as therapeutic viruses targeted to infect and destroy cancer cells. For such applications, the viruses are often equipped with additional genes, such as for immune mediators or for proteins inducing programmed cell death. However, these gene products can harm the body if they are released at the wrong moment or at excessive levels. "Ideally, we want to be able to turn on and off the transferred genes at a specific time," says Dr. Dirk Nettelbeck, ...

New technology to transform blood processing

2012-08-21

A pioneering surgical blood salvage technology developed at the University of Strathclyde, Glasgow, is set to transform the way major surgery is carried out by reducing blood loss in patients. HemoSep is set to revolutionise the health care sector after gaining the CE mark and receiving Canadian national approval, following highly successful clinical trials in the world leading University of Kirikkale University Hospital in Ankara, Turkey. The device is designed to recover blood spilled during open-heart and major trauma surgery and concentrate the blood cells for transfusion ...

Dawn of humanity illuminated in special journal edition – 50 years after the Leakeys

2012-08-21

The first systematic, multidisciplinary results to come out of research conducted on the edge of the Serengeti at the rich palaeoanthropological site in the Olduvai Gorge in Tanzania since that produced by Louis and Mary Leakey's team, have recently been published in a special issue of the prestigious Journal of Human Evolution. Professor Marion Bamford, deputy director of the Bernard Price Institute for Palaeontological Research, and Professor Ron Clarke from the Institute of Human Evolution – both at the University of the Witwatersrand – contributed papers to the 191-page ...

Stem cells can become anything – but not without this protein

2012-08-21

ANN ARBOR, Mich. — How do stem cells preserve their ability to become any type of cell in the body? And how do they "decide" to give up that magical state and start specializing? If researchers could answer these questions, our ability to harness stem cells to treat disease could explode. Now, a University of Michigan Medical School team has published a key discovery that could help that goal become reality. In the current issue of the prestigious journal Cell Stem Cell, researcher Yali Dou, Ph.D., and her team show the crucial role of a protein called Mof in preserving ...

Flood risk ranking reveals vulnerable cities

2012-08-21

A new study of nine coastal cities around the world suggests that Shanghai is most vulnerable to serious flooding. European cities top the leader board for their resilience. These finding are based on a new method to calculate the flood vulnerability of cities, developed by a team of researchers from the Netherlands and the University of Leeds. The work is published in the latest edition of the journal Natural Hazards. The index does not just look at the likelihood of a city's exposure to a major 'once in a hundred years' flood. The researchers have been careful to ...

Equality laws fail to protect working women from budget cuts

2012-08-21

The UK government has failed to apply laws that protect working women in the wake of the economic crisis, suggests a new study from Queen Mary, University of London. The article analyses The Fawcett Case, a high-profile legal challenge to the 2010 emergency budget on the grounds that it would have a disproportionately negative impact on women. The paper also charts how equality legislation has created opportunities for women's rights groups to influence industrial relations; traditionally, trade union territory. The research was carried out by Dr Hazel Conley, from ...

Language barrier creates legal hurdles for Brits in Turkey

2012-08-21

Many Brits who move to Turkey are failing to grasp local and international laws, leaving them financially at risk when making legal transactions, such as buying property, a study from Queen Mary, University of London has found. Being unable to speak or read Turkish has made navigating such issues a "legal minefield" for many Brits who emigrate in a quest for the affordable "good life" on the Aegean coast. Funded by the Nuffield Foundation, the study focuses on British citizens settling in Mugla, a popular tourist spot in Turkey, and their social and legal experiences ...

Catalan researchers identify a key component of cell division

2012-08-21

This press release is available in Spanish and in French - The Nek9 protein is required for chromosomes to separate into two identical groups. - Nek9 exerts its action between two molecules of interest for the pharmaceutical industry as anti-tumoral agents, and for which inhibitors are already in advanced stages of clinical trials. Nek9 could be added to the list of candidates. A study by the Institute for Research in Biomedicine (IRB Barcelona) and the Center for Genomic Regulation (acronym in Catalan CRG) highlights the protein Nek9 as a decisive factor in cell ...

No ordinary forget-me-nots

2012-08-21

Two rare species of forget-me-nots have been added to Flora of New Zealand. These new species were discovered in the mountains of the South Island during an expedition led by Dr. Carlos A. Lehnebach. These new species have been described and illustrated in an article published in the open access journal PhytoKeys. The expedition was part of a major endeavour by a group of botanists at the Museum of New Zealand Te Papa Tongarewa in partnership with Landcare Research aiming to describe and list all forget-me-nots (Myosotis) found in New Zealand. Dr. Lehnebach, who is a ...

'Alzheimer protein' seems to slow down neurotransmitter production

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: